Inactive Instrument

Press Releases 3D Signatures Inc Toronto S.E.

Equities

CA88555C1077

Press Releases

Unlock all the news: Be the first to know and act before the market!

Telo Genomics Announces Its TeloViewSMM Test Is Accepted as Laboratory Developed Test by CAP	06-18	NE
Telo Genomics Presents Proprietary Artificial Intelligence Methodologies at ASCO 2024	06-12	NE
Telo Genomics Announces Publication of Results from Its Smoldering Myeloma Clinical Study in the American Journal of Hematology	05-30	NE
Telo Genomics and Emery Pharma Announce Collaboration	05-15	NE
Telo Genomics Receives Accreditation from College of American Pathologists	04-10	NE
Telo Genomics' Flagship MRD Clinical Trial Expands into Multi-Center Trial	04-02	NE
Telo Genomics Initiates MRD Clinical Trial for Multiple Myeloma Patients	02-13	NE
Telo Genomics Engages US Diagnostics Experts to Power Product Adoption in the US	01-30	NE
Telo Genomics Gears up for American Society of Hematology Conference	12-06	NE
Telo Genomics Launches Physician Experience Program in the United States	11-16	NE
Telo Genomics Advances to the Final Stage of Accreditation from The College of American Pathologists	11-07	NE
American Society of Hematology (ASH) Accepts Validation Data from Telo Genomics for Presentation at Upcoming Annual Meeting	11-01	NE
Telo Genomics : Consolidated Financial Statements	29/10/23	PU
Telo Genomics Completes International Standards Organization ("ISO") 15189 Final Accreditation	26/10/23	NE
Telo Genomics Announces Clinical Launch of Non-Invasive Cancer Diagnostic, TeloViewSMM - An Important Commercial Milestone Achieved	17/10/23	NE
Telo Genomics Presents Positive Results in Assessing MRD in Multiple Myeloma Patients at the International Myeloma Society Annual Meeting	12/10/23	NE
Telo Genomics Completes Oversubscribed Private Placement	15/06/23	AQ
Telo Genomics Achieves a Major Milestone - Results of Smoldering Myeloma Study Accepted for Presentation at ASCO Annual Meeting	14/04/23	AQ
Telo Genomics : Q1 - 2023	16/11/22	PU
Telo Genomics Engages Key Opinion Leader to Form and Chair Myeloma Advisory Board	19/10/22	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases 3D Signatures Inc Toronto S.E.

Equities

CA88555C1077

Press Releases

Filters